Leaky ship........I smell an announcement, page-13

The Australian market has 6.4 million females between the ages of 15 and 64.

If the U.S research was accurate then Australia should follow the U.S. in finding that about 30% have had BV at some time and a smaller number have a chronic condition requiring a preventative regime.

So the potential pool of users is probably around 2M in Australia alone. And some more in NZ.

My minuscule survey of pharmacists I use reveals that Aspen has said nothing so far, but that a BV treatment would be very very welcome by the pharmacy profession. To quote both of them "It would be huge" and, did I know when it would be released.

This of course reveals the fact that Aspen has done nothing noticeable about promoting a unique treatment for a very common female condition. And one which could potentially be valuable to their business and the pharmacies they supply.

And why will our company not announce a date, instead of waffling on about about busy plans, and product being manufactured. If they have any sort of plan then they MUST HAVE a date. Perhaps they are frightened to miss another deadline!

NOT GOOD ENOUGH Jackie, announce the planned dates and work with your partners to meet them! That is what we pay you for.